Sep 2026· Biochimica et Biophysica Acta - Molecular Basis of Disease· Vol 1873, pp.
168469
· 0 citations· 302 references
Medicine
TL;DR
Overall, available evidence identifies lncRNAs as key mediators of gastric carcinogenesis and as potential diagnostic biomarkers and therapeutic targets.
Abstract
Long non-coding RNAs (lncRNAs) are now recognized as important modulators of gene expression acting at the transcriptional, post-transcriptional, and epigenetic levels. A growing number of studies suggest that abnormal lncRNA expression plays a critical role in gastric carcinogenesis by controlling cellular functions such as proliferation, cell-cycle progression, apoptosis, autophagy, and other forms of regulated cell death. This review discusses the molecular pathways through which lncRNAs contribute to gastric carcinogenesis, particularly by regulating cell fate, proliferation, and apoptosis. We also summarize the functions of major oncogenic and tumor-suppressive lncRNAs, including HOTAIR, MALAT1, H19, GAS5, DINO, PANDAR and their associations with PI3K/AKT, Wnt/β-catenin, MAPK, JAK/STAT, and p53 signaling. Associations among lncRNAs, ferroptosis, treatment response, and tumor progression are also discussed. Overall, available evidence identifies lncRNAs as key mediators of gastric carcinogenesis and as potential diagnostic biomarkers and therapeutic targets.
GAS6-AS1 represents a promising molecule for understanding cancer pathogenesis and developing novel strategies for precision cancer diagnosis and treatment, although further clinical validation and mechanistic studies are still required.
Zhi-Ling Lu, Wen-Bing Huang, Jin-Tao He et al.· Biomedical Reports· 0 citations
This review provides a comprehensive overview of the current understanding of lncRNA-mediated regulation of EMT and metastasis in gastric cancer and provides insights into the complex regulatory networks governed by lncRNAs, highlighting their translational potential in improving GC management.
M. Saadh, A. K. Bishoyi, R. Roopashree et al.· Biochemistry and Biophysics...· 0 citations
This review examines how different types of ncRNAs contribute to cancer initiation, progression, and treatment resistance, and assesses their potential as diagnostic markers, prognostic factors, and therapeutic targets.
Akanksha Samuel, G. Calin· Carcinogenesis· 0 citations
A review of recent advances in understanding the regulatory role of ncRNAs on the PD-1/ PD-L1 pathway in brain cancer tumorigenesis highlights promising opportunities for developing therapeutic interventions against brain cancer.
Reihane Behnam-Rassouli, Farzaneh Entezari, Majid Ghorbanzadeh et al.· Iranian Journal of Basic Med...· 0 citations
Background/Objectives: Papillary thyroid cancer (PTC) is the most common endocrine malignancy and is generally associated with favorable clinical outcomes. However, a subset of tumors develops aggressive phenotypes characterized by increased proliferation, migration, therapeutic resistance, and disease progression. Lon...
D. Quaranto, N. DeSouza, Michelle Carnazza et al.· Genes· 0 citations
It is suggested that UPK1A-AS1 is a hypoxia‐inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type‐dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia‐associated drug resistance in HCC.
Ze-Kai Li, Min Luo, Shu-Sen Fang et al.· Analytical Cellular Patholog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.